Disruption in the TSC1/TSC2 complex leads to constitutive activation of mTORC1, resulting in unchecked protein synthesis, cell cycle progression, and ultimately the development of benign tumors, or hamartomas, characteristic of TSC. This evidence concerns the gene TSC2 and hamartoma.